Partnering with Global Alliance for Rabies Control (GARC) and community partners to vaccinate 12,000 dogs and cats across the Philippines, Indonesia, Malaysia, and Vietnam in 2022
Empowering employees and social entrepreneurs to pilot and scale accessible health solutions through its signature ‘Making More Health’ flagship initiative
Committing to carbon neutrality in company operations by 2030 (Scope 1 and 2), reducing operational waste, and eliminating single-use plastic
Boehringer Ingelheim is strengthening its commitment to positively impact people, animals, communities, and the planet through key sustainability initiatives in the Philippines and across ASEAN, South Korea, Australia, and New Zealand (ASKAN).
Under the ‘Sustainable Development – For Generations’ framework, Boehringer Ingelheim has globally pledged EUR 250 million to combat infectious diseases in humans and animals, expanding healthcare access for non-communicable diseases for 50 million people in vulnerable communities, including in the ASKAN area, and invest EUR 35 billion in health innovation to tackle non-communicable diseases. In addition to improving access to healthcare, Boehringer Ingelheim is committed to carbon neutrality in company operations by 2030 (Scope 1 and 2) and is taking steps to contribute to food security and safety, building a sustainable and healthy future for all.
